CGT9486
PLX121-01
Phase 2 small_molecule completed
Quick answer
CGT9486 for Gastrointestinal Stromal Tumors is a Phase 2 program (small_molecule) at Cogent Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cogent Biosciences
- Indication
- Gastrointestinal Stromal Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed